Stefania Bernardi
Overview
Explore the profile of Stefania Bernardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
852
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernardi S, Roversi M, Torelli A, Musolino A, Nicastri E, Palma P, et al.
Pediatr Infect Dis J
. 2025 Jan;
PMID: 39774678
Introduction: Despite the generally mild course of COVID-19 in children, immunocompromised patients may experience complications or severe infection. This study reports the clinical outcomes of pediatric patients treated with nirmatrelvir...
2.
Fernandes G, Chappell E, Goetghebuer T, Kahlert C, Ansone S, Bernardi S, et al.
HIV Med
. 2024 Oct;
26(2):207-217.
PMID: 39444189
Objectives: This survey was conducted to describe current European postnatal prophylaxis (PNP) and infant feeding policies with the aim of informing future harmonized guidelines. Methods: A total of 32 senior...
3.
Pighi C, Rotili A, De Luca M, Chiurchiu S, Calo Carducci F, Rossetti C, et al.
Viruses
. 2024 May;
16(5).
PMID: 38793661
Human cytomegalovirus (CMV) is a common herpesvirus causing lifelong latent infection in most people and is a primary cause of congenital infection worldwide. Given the role of NK cells in...
4.
Cotugno N, Neri A, Sanna M, Santilli V, Manno E, Pascucci G, et al.
JCI Insight
. 2024 May;
9(10).
PMID: 38775152
Children with perinatally acquired HIV (PHIV) have special vaccination needs, as they make suboptimal immune responses. Here, we evaluated safety and immunogenicity of 2 doses of 4-component group B meningococcal...
5.
Mercadante S, Ficari A, Romani L, De Luca M, Tripiciano C, Chiurchiu S, et al.
Children (Basel)
. 2024 Apr;
11(4).
PMID: 38671600
Invasive infections caused by (iGAS), commonly known as Group A Streptococcus, represent a significant public health concern due to their potential for rapid progression and life-threatening complications. Epidemiologically, invasive GAS...
6.
Scutari R, Fox V, Fini V, Granaglia A, Vittucci A, Smarrazzo A, et al.
Sci Rep
. 2024 Mar;
14(1):5325.
PMID: 38438451
Since its emergence, SARS-CoV-2 Omicron clade has shown a marked degree of variability and different clinical presentation compared with previous clades. Here we demonstrate that at least four Omicron lineages...
7.
Romani L, Roversi M, Bernardi S, Venturini E, Garazzino S, Dona D, et al.
Ital J Pediatr
. 2024 Feb;
50(1):32.
PMID: 38413992
Background: COVID-19 is generally milder in children than in adults, however severe infection has been described in some patients. Few data are available on use of Remdesivir (RDV) in children,...
8.
Leone F, Cotugno N, Casamento Tumeo C, Zangari P, Palomba P, Adorisio R, et al.
BMC Infect Dis
. 2023 Jul;
23(1):477.
PMID: 37464267
Introduction: Haemophagocytic lymphohistiocytosis is a rare and life-threatening condition caused by uncontrolled immune activation leading to excessive inflammation and tissue destruction. It could either be due to a primary genetic...
9.
Leone F, Di Giuseppe M, De Luca M, Cursi L, Calo Carducci F, Krzysztofiak A, et al.
Children (Basel)
. 2023 May;
10(5).
PMID: 37238411
Coronavirus disease 2019 (COVID-19) and tuberculosis (TB) are currently two major causes of death among infectious diseases. Active tuberculosis and a history of tuberculosis appear to be associated with an...
10.
Alteri C, Fox V, Scutari R, Burastero G, Volpi S, Faltoni M, et al.
Commun Biol
. 2022 Dec;
5(1):1376.
PMID: 36522489
Little is known about SARS-CoV-2 evolution under Molnupiravir and Paxlovid, the only antivirals approved for COVID-19 treatment. By investigating SARS-CoV-2 variability in 8 Molnupiravir-treated, 7 Paxlovid-treated and 5 drug-naïve individuals...